000 | 01116 a2200349 4500 | ||
---|---|---|---|
005 | 20250513112723.0 | ||
264 | 0 | _c19970429 | |
008 | 199704s 0 0 eng d | ||
022 | _a1081-0943 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSanda, M G | |
245 | 0 | 0 |
_aBiological principles and clinical development of prostate cancer gene therapy. _h[electronic resource] |
260 |
_bSeminars in urologic oncology _cFeb 1997 |
||
300 |
_a43-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdenoviridae |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aGene Transfer Techniques |
650 | 0 | 4 | _aGenes, Tumor Suppressor |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 | _aGenetic Vectors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xtherapy |
650 | 0 | 4 | _aOligonucleotides, Antisense |
650 | 0 | 4 | _aPoxviridae |
650 | 0 | 4 |
_aProstatic Neoplasms _xtherapy |
650 | 0 | 4 | _aRNA, Catalytic |
650 | 0 | 4 | _aRetroviridae |
773 | 0 |
_tSeminars in urologic oncology _gvol. 15 _gno. 1 _gp. 43-55 |
|
999 |
_c9038334 _d9038334 |